A business in context
RVMD research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-09-25 | Mancini Anthony | S · Sale | Common Stock | 3121.0 | 200.54 |
| 2026-09-25 | Mancini Anthony | M · Exercise / conversion | Common Stock | 3121.0 | 33.62 |
| 2026-09-25 | Mancini Anthony | M · Exercise / conversion | Stock Option (Right to Buy) | 3121.0 | 0.0 |
| 2026-09-25 | Cislini Jeff | S · Sale | Common Stock | 765.0 | 207.32 |
| 2026-09-24 | Mancini Anthony | S · Sale | Common Stock | 587.0 | 200.0 |
| 2026-09-22 | ANDERSON ELIZABETH M | S · Sale | Common Stock | 100.0 | 195.15 |
| 2026-09-22 | ANDERSON ELIZABETH M | S · Sale | Common Stock | 2648.0 | 193.44 |
| 2026-09-22 | ANDERSON ELIZABETH M | S · Sale | Common Stock | 4985.0 | 192.54 |
| 2026-09-22 | ANDERSON ELIZABETH M | S · Sale | Common Stock | 910.0 | 191.85 |
| 2026-09-22 | ANDERSON ELIZABETH M | M · Exercise / conversion | Common Stock | 5070.0 | 1.12 |
| 2026-09-22 | ANDERSON ELIZABETH M | S · Sale | Common Stock | 1500.0 | 194.59 |
| 2026-09-22 | ANDERSON ELIZABETH M | M · Exercise / conversion | Stock Option (Right to Buy) | 5070.0 | 0.0 |
| 2026-09-18 | Mancini Anthony | S · Sale | Common Stock | 1764.0 | 196.94 |
| 2026-09-16 | Mancini Anthony | S · Sale | Common Stock | 1747.0 | 199.3 |
| 2026-09-16 | Mancini Anthony | S · Sale | Common Stock | 27.0 | 195.05 |
| 2026-09-16 | Cislini Jeff | S · Sale | Common Stock | 52.0 | 195.01 |
| 2026-09-16 | Cislini Jeff | S · Sale | Common Stock | 3314.0 | 199.3 |
| 2026-09-16 | Sandler Alan B. | S · Sale | Common Stock | 336.0 | 199.3 |
| 2026-09-16 | Sandler Alan B. | S · Sale | Common Stock | 5.0 | 194.96 |
| 2026-09-16 | Anders Jack | S · Sale | Common Stock | 3992.0 | 199.3 |
| 2026-09-16 | Anders Jack | S · Sale | Common Stock | 61.0 | 195.0 |
| 2026-09-16 | Kelsey Stephen Michael | S · Sale | Common Stock | 85.0 | 195.01 |
| 2026-09-16 | Kelsey Stephen Michael | S · Sale | Common Stock | 5484.0 | 199.3 |
| 2026-09-16 | Horn Margaret A | S · Sale | Common Stock | 4891.0 | 199.3 |
| 2026-09-16 | Horn Margaret A | S · Sale | Common Stock | 76.0 | 195.01 |
| 2026-09-16 | GOLDSMITH MARK A | S · Sale | Common Stock | 213.0 | 195.01 |
| 2026-09-16 | GOLDSMITH MARK A | S · Sale | Common Stock | 13775.0 | 199.3 |
| 2026-09-11 | Kelsey Stephen Michael | S · Sale | Common Stock | 3270.0 | 205.81 |
| 2026-09-11 | Kelsey Stephen Michael | S · Sale | Common Stock | 4995.0 | 204.84 |
| 2026-09-11 | Kelsey Stephen Michael | S · Sale | Common Stock | 17949.0 | 203.87 |
| 2026-09-11 | Kelsey Stephen Michael | S · Sale | Common Stock | 18869.0 | 203.06 |
| 2026-09-11 | Kelsey Stephen Michael | S · Sale | Common Stock | 21447.0 | 201.75 |
| 2026-09-11 | Kelsey Stephen Michael | S · Sale | Common Stock | 13368.0 | 200.78 |
| 2026-09-11 | Kelsey Stephen Michael | S · Sale | Common Stock | 11833.0 | 200.11 |
| 2026-09-11 | Kelsey Stephen Michael | S · Sale | Common Stock | 800.0 | 198.55 |
| 2026-09-11 | Kelsey Stephen Michael | M · Exercise / conversion | Common Stock | 52500.0 | 42.45 |
| 2026-09-11 | Kelsey Stephen Michael | M · Exercise / conversion | Common Stock | 40031.0 | 40.74 |
| 2026-09-11 | Kelsey Stephen Michael | M · Exercise / conversion | Stock Option (Right to Buy) | 40031.0 | 40.74 |
| 2026-09-11 | Kelsey Stephen Michael | M · Exercise / conversion | Stock Option (Right to Buy) | 52500.0 | 42.45 |
| 2026-09-10 | Mancini Anthony | S · Sale | Common Stock | 2420.0 | 205.05 |
| 2026-09-10 | Mancini Anthony | S · Sale | Common Stock | 1179.0 | 206.1 |
| 2026-09-10 | Mancini Anthony | S · Sale | Common Stock | 300.0 | 207.17 |
| 2026-09-10 | Mancini Anthony | S · Sale | Common Stock | 6019.0 | 203.28 |
| 2026-09-10 | Mancini Anthony | M · Exercise / conversion | Common Stock | 9363.0 | 33.62 |
| 2026-09-10 | Mancini Anthony | S · Sale | Common Stock | 5530.0 | 204.14 |
| 2026-09-10 | Mancini Anthony | M · Exercise / conversion | Stock Option (Right to Buy) | 9363.0 | 0.0 |
| 2026-09-08 | Kim Lorence H. | S · Sale | Common Stock | 706.0 | 206.6 |
| 2026-09-08 | Kim Lorence H. | S · Sale | Common Stock | 999.0 | 207.33 |
| 2026-09-08 | Kim Lorence H. | S · Sale | Common Stock | 3587.0 | 208.55 |
| 2026-09-08 | Kim Lorence H. | S · Sale | Common Stock | 371.0 | 212.27 |
Identity & relationships
SEC issuer · 0001628171Revolution Medicines, Inc.
- Legal Entity Identifier
- 549300JU3X0LBCQ65892
- GLEIF legal name
- REVOLUTION MEDICINES, INC.
- Entity / LEI registration status
- ACTIVE / LAPSED
- Reference data updated
- 2026-08-12T14:58:24Z
Search names and former names
View Wikidata identity and references ↗
- Revolution Medicines (United States) · alias · wikidata
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $0 | $0 |
| 2023-12-31 | $11.58M | $12.80M |
| 2022-12-31 | $35.38M | $40.73M |
| 2021-12-31 | $29.39M | $36.54M |
| 2020-12-31 | $42.98M | $55.96M |
| 2019-12-31 | $50.04M | $65.95M |
| 2018-12-31 | $20.16M | $27.06M |